FDA panel to discuss safety of Bayer’s contraceptive device Essure

(Reuters) – The U.S. Food and Drug Administration said it would discuss the safety and effectiveness of Bayer AG’s controversial contraceptive device, Essure, in a public panel meeting after receiving more than 5000 complaints, including those of deaths and pregnancies. Essure, which is the only approved permanent birth control device in the United States, is a small metal coil that is placed in the fallopian tubes through a catheter. The FDA approved the device in November 2002.
Sexual Health News Headlines – Yahoo! News